Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray

Endocrinology

Volumn 144, Issue 4, 2003, Pages 1257-1265

  Jiang, Feng ^a   Wang, Zhou ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; COMPLEMENTARY DNA; DNA FRAGMENT; GENE PRODUCT; MIBOLERONE; SCLEROPROTEIN; TESTOSTERONE PROPIONATE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CASTRATION; CELL CYCLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA SEQUENCE; DOWN REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE ISOLATION; GENETIC ANALYSIS; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; MALE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RAT; SEQUENCE TAGGED SITE; SUBTRACTIVE HYBRIDIZATION; UNINDEXED SEQUENCE; UPREGULATION; VALIDATION PROCESS;

ANDROGENS; ANIMALS; EVOLUTION, MOLECULAR; GENE EXPRESSION; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE; PROSTATIC NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0037387184     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220718     Document Type: Article

References (48)

1. Huggins C 1967 Endocrine-induced regression of cancers. Cancer Res 27:1925-1930
2. Wang Z, Tufts R, Haleem R, Cai X 1997 Genes regulated by androgen in the rat ventral prostate. Proc Natl Acad Sci USA 94:12999-13004
3. Blok LJ, Kumar MV, Tindall DJ 1995 Isolation of cDNAs that are differentially expressed between androgen-dependent and androgen-independent prostate carcinoma cells using differential display PCR. Prostate 26:213-224
4. Xu LL, Su YP, Labiche R, Segawa T, Shanmugam N, McLeod DG, Moul JW, Srivastava S 2001 Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int J Cancer 92:322-328
5. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM 2000 Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 60:6134-6141
6. Prescott JL, Blok L, Tindall DJ 1998 Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 35:71-80
7. Ulrix W, Swinnen JV, Heyns W, Verhoeven G 1998 Identification of the phosphatidic acid phosphatase type 2a isozyme as an androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaP. J Biol Chem 273:4660-4665
8. Betts AM, Waite I, Neal DE, Robson CN 1997 Androgen regulation of ornithine decarboxylase in human prostatic cells identified using differential display. FEBS Lett 405:328-332
9. Waghray A, Feroze F, Schober MS, Yao F, Wood C, Puravs E, Krause M, Hanash S, Chen YQ 2001 Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 1:1327-1338
10. Clegg N, Eroglu B, Ferguson C, Arnold H, Moorman A, Nelson PS 2002 Digital expression profiles of the prostate androgen-response program. J Steroid Biochem Mol Biol 80:13-23
11. Young CY, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ 1991 Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. Cancer Res 51:3748-3752
12. Wilson EM, French FS 1980 Biochemical homology between rat dorsal prostate and coagulating gland. Purification of a major androgen-induced protein. J Biol Chem 255:10946-10953
13. Murtha P, Tindall DJ, Young CY 1993 Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 32:6459-6464
14. Page MJ, Parker MG 1982 Effect of androgen on the transcription of rat prostatic binding protein genes. Mol Cell Endocrinol 27:343-355
15. Partin AW, Catalona WJ, Finlay JA, Darte C, Tindall DJ, Young CY, Klee GG, Chan DW, Rittenhouse HG, Wolfert RL, Woodrum DL 1999 Use of human glandular kallikrein 2 for the detection of prostate cancer: preliminary analysis. Urology 54:839-845
16. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, Milbrandt J 2002 Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 22:1495-1503
17. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM 1999 Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13:966-977
18. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C 2002 Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 99:2884-2889
19. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP 2000 Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 60:6111-6115
20. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM 1995 Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439-3443
21. Wang Z, Brown DD 1991 A gene expression screen. Proc Natl Acad Sci USA 88:11505-11509
22. Winderickx J, Hemschoote K, De Clercq N, Van Dijck P, Peeters B, Rombauts W, Verhoeven G, Heyns W 1990 Tissue-specific expression and androgen regulation of different genes encoding rat prostatic 22-kilodalton glycoproteins homologous to human and rat cystatin. Mol Endocrinol 4:657-667
23. Furuya Y, Lin XS, Walsh JC, Nelson WG, Isaacs JT 1995 Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136:1898-1906
24. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV 2001 Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 15:1817-1828
25. Sahlin L, Wang H, Masironi B, Holmgren A, Eriksson H 1999 Regulation of thioredoxin mRNA in the rat uterus by gonadal steroids. J Steroid Biochem Mol Biol 68:203-209
26. Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL, Pollak M 2001 In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res 61:6276-6280
27. Nickerson T, Pollak M, Huynh H 1998 Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4 and 5. Endocrinology 139:807-810
28. Shen R, Sumitomo M, Dai J, Hardy DO, Navarro D, Usmani B, Papandreou CN, Hersh LB, Shipp MA, Freedman LP, Nanus DM 2000 Identification and characterization of two androgen response regions in the human neutral endopeptidase gene. Mol Cell Endocrinol 170:131-142
29. Marcantonio D, Chalifour LE, Alaoui-Jamali MA, Huynh HT 2001 Steroid-sensitive gene-1 is an androgen-regulated gene expressed in prostatic smooth muscle cells in vivo. J Mol Endocrinol 26:175-184
30. Swinnen JV, Ulrix W, Heyns W, Verhoeven G 1997 Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 94:12975-12980
31. Swinnen JV, Esquenet M, Heyns W, Rombauts W, Verhoeven G 1994 Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP. Mol Cell Endocrinol 104:153-162
32. Bettuzzi S, Hiipakka RA, Gilna P, Liao ST 1989 Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem J 257:293-296
33. 2+-dependent endonuclease as an early event in castration-induced prostatic cell death. Prostate 13:103-117
34. Zhu N, Wang Z 1999 Calreticulin expression is associated with androgen regulation of the sensitivity to calcium ionophore-induced apoptosis in LNCaP prostate cancer cells. Cancer Res 59:1896-1902
35. Tamatani M, Matsuyama T, Yamaguchi A, Mitsuda N, Tsukamoto Y, Taniguchi M, Che YH, Ozawa K, Hori O, Nishimura H, Yamashita A, Okabe M, Yanagi H, Stern DM, Ogawa S, Tohyama M 2001 ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med 7:317-323
36. Darson MF, Pacelli A, Roche P, Rittenhouse HG, Wolfert RL, Young CY, Klee GG, Tindall DJ, Bostwick DG 1997 Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker. Urology 49:857-862
37. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
38. DiGiovanni J, Kiguchi K, Frijhoff A, Wilker E, Bol DK, Beltran L, Moats S, Ramirez A, Jorcano J, Conti C 2000 Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 97:3455-3460
39. Barnes J, Anthony CT, Wall N, Steiner MS 1995 Bone morphogenetic protein-6 expression in normal and malignant prostate. World J Urol 13:337-343
40. Usmani BA, Shen R, Janeczko M, Papandreou CN, Lee WH, Nelson WG, Nelson JB, Nanus DM 2000 Methylation of the neutral endopeptidase gene promoter in human prostate cancers. Clin Cancer Res 6:1664-1670
41. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM 1998 Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 4:50-57
42. Dai J, Shen R, Sumitomo M, Goldberg JS, Geng Y, Navarro D, Xu S, Koutcher JA, Garzotto M, Powell CT, Nanus DM 2001 Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin Cancer Res 7:1370-1377
43. Young CY, Seay T, Hogen K, Charlesworth MC, Roche PC, Klee GG, Tindall DJ 1996 Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer. Prostate Suppl 7:17-24
44. Bauer HW 1988 Acid phosphatase, alkaline phosphatase and prostate-specific antigen - usefulness in the diagnosis of metastatic disease and follow-up. Prog Clin Biol Res 269:33-42
45. Autzen P, Robson CN, Bjartell A, Malcolm AJ, Johnson MI, Neal DE, Hamdy FC 1998 Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer 78:1219-1223
46. Sugimoto A, Hozak RR, Nakashima T, Nishimoto T, Rothman JH 1995 DAD1, an endogenous programmed cell death suppressor in Caenorhabditis elegans and vertebrates. EMBO J 14:4434-4441
47. Hong NA, Flannery M, Hsieh SN, Cado D, Pedersen R, Winoto A 2000 Mice lacking Dad1, the defender against apoptotic death-1, express abnormal N-linked glycoproteins and undergo increased embryonic apoptosis. Dev Biol 220:76-84
48. Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC 1999 Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by over-expression of TIMP3. Br J Cancer 79:1347-1355